Meeting
2023 ASCO Annual Meeting
Immunotherapy for localized MSI-H colorectal cancer: Characterizing endoscopic and imaging response.
Authors
Daniel Aaron Fox
Baylor College of Medicine, Houston, TX
Daniel Aaron Fox , Tsuyoshi Konishi , Harmeet Kaur , Y. Nancy You , Kanwal Pratap Singh Raghav , Phillip S. Ge , Craig Messick , Benny Johnson , Van K. Morris II, Jane V Thomas , Preksha Shah , Brian K. Bednarski , Scott Kopetz , George J. Chang , Kaysia Ludford , Victoria Higbie , Michael J. Overman , Deepak Bhamidipati
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3610)
DOI
10.1200/JCO.2023.41.16_suppl.3610
Abstract #
3610
Poster Bd #
310
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Assessment of complete pathologic response after neoadjuvant immunotherapy for MSI-H gastrointestinal cancers.
First Author: Kruti Bhagirath Vora
Poster
2023 ASCO Annual Meeting
Immunotherapy for localized dMMR/MSI tumors: First interim analysis of the IMHOTEP trial.
First Author: Christelle De La Fouchardiere
Poster
2021 Gastrointestinal Cancers Symposium
Response to PD-1 and PD-L1 based immunotherapy in MSS advanced colorectal cancer is impacted by metastatic disease sites.
First Author: Marwan Fakih
Poster
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Real-world evidence data (RWED) of financial toxicity (FT) in patients (pts) receiving cancer immunotherapy treatments.
First Author: Daniel A. Vorobiof